FHN Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
First Horizon Corp (FHN) is not a strong buy at the moment for a beginner investor with a long-term strategy. While the stock has stable technical indicators and hedge funds are showing strong buying interest, the lack of significant positive catalysts, recent analyst downgrades, and limited upside potential make it prudent to hold off on investing right now.
The MACD is positive and contracting, RSI is neutral at 56.541, and moving averages are bullish (SMA_5 > SMA_20 > SMA_200). The stock is trading near its pivot level of 24.747, with resistance at 25.252 and support at 24.243. Overall, the technical indicators suggest a stable but not strongly bullish trend.
Hedge funds are aggressively buying, with a 9532.83% increase in the last quarter. The company is expanding its leadership team and strengthening its position in healthcare financial services, which could support long-term growth.
Recent analyst downgrades and reduced price targets reflect uncertainty around earnings and valuation. UBS downgraded the stock to Neutral, citing limited upside without a takeover announcement. Broader macro concerns like rising costs of equity, AI disruption, and geopolitical risks also weigh on sentiment.
No financial data available for the latest quarter. Q2 financial results are expected on July 15, 2026.
Analyst sentiment is mixed, with price targets ranging from $25 to $29. Recent downgrades and reduced price targets highlight concerns about limited upside and macroeconomic uncertainties.
